Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-05

Clinical Trial Update: Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care [NA]

View source ↗

Summary

A completed clinical trial compared Helicoll collagen dressings with standard of care for treating wounds in patients with epidermolysis bullosa; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Helicoll Collagen Dressing (collagen dressing)

Snippet

Sponsor: Stanford University | Conditions: Epidermolysis Bullosa Dystrophica, Epidermolysis Bullosa | NA | Status: COMPLETED | Results posted: 2016-05-05